Patent · US Active

Pharmaceutical compositions

US10016449B2 · kind B2 · utility

0Cited by

41References

27Claims

0Family size

Assignee

MOMENTA PHARMACEUTICALS, INC. · US

Inventors

Kelly Neelon · Newburyport, US
Gary Mills · Groveland, US
James E. Anderson · Madison, US

Key dates

Filing date	May 27, 2014
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Oct 7, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are pharmaceutical compositions comprising a LMWH preparation having at least one chain having a glycol split uronic acid residue (UG) in the preparation and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.